Dana-Farber Cancer Institute
Dana-Farber Cancer Institute provides expert, compassionate care to children and adults while advancing the understanding, diagnosis, treatment, and prevention of cancer and related diseases. Dana-Farber, with its partners, is ranked among the nation's very top cancer centers, and is one of the world's leading center for research into the causes of---and new treatments for---the disease.To make an appointment, visit www.dana-farber.org or call the following numbers for:
Adults: +1 877-442-3324 (+1 877-442-DFCI)
Children: +1 888-733-4662 (+1 888-PEDI-ONC)
Dana-Farber shares patient stories which may include descriptions of actual medical results. Dana-Farber provides personalized care for each patient based on their unique needs; their experiences and results will vary.
- 0:52
- 4 сағат бұрын
How Can I Reduce My Risk of Colorectal Cancer?
- 28:40
- 7 сағат бұрын
Exercise and Brain Tumors | 2024 Glioma Specialists Reaching Out With (GROW) Support Symposium
- 29:59
- 7 сағат бұрын
Sexuality & Dating with Glioma | 2024 Glioma Specialists Reaching Out With (GROW) Support Sym...
- 26:56
- 7 сағат бұрын
Brain Tumor Symptoms | 2024 Glioma Specialists Reaching Out With (GROW) Support Symposium
- 1:12
- 9 сағат бұрын
What is Targeted Protein Degradation?
- 1:55
- 19 сағат бұрын
Xiao Wei, MD, MA on Prostate LuPSMA research at AUA24 | Dana-Farber Cancer Institute
- 13:27
- 19 сағат бұрын
Blum Spotlight on Dana-Farber Resources: Mind, Body, Spirit, Medicine
- 52:49
- 19 сағат бұрын
NOW Program Educational Webinars: Surgical Approaches for Brain Tumors
- 1:03
- 21 сағат бұрын
What's the Association Between Drinking Alcohol and Cancer?
- 30:46
- Күн бұрын
Managing Your Finances During Cancer: Legacy Planning
- 3:36
- Күн бұрын
How to do Crescent Lunge Pose, with Chair Modification | Dana-Farber Zakim Center Remote Programming
- 2:34
- 14 күн бұрын
Love Beyond Loss: A wife's journey after losing her husband to cancer | Dana-Farber Cancer I...
- 43:40
- 14 күн бұрын
Health Literacy & Barriers to Engaging People in Clinical Trials | 2023 BRCA Scientific Sympo...
- 41:46
- 14 күн бұрын
Haploinsufficient Phenotypes of BRCA1/2-Mutant Breast Tissue | 2023 BRCA Scientific Symposium
- 52:15
- 14 күн бұрын
Understanding and Overcoming PARP Inhibitor Resistance
- 50:25
- 14 күн бұрын
Synthetic Lethal Interactions of BRCA1 in Stalled-Fork Repair | 2023 BRCA Scientific Symposium
- 45:28
- 14 күн бұрын
DDR Deficiency and Replication Stress in Pancreatic Cancer | 2023 BRCA Scientific Symposium
- 24:20
- 14 күн бұрын
Future of Novel Next Generation Therapy in the Management of Relapsed/Refractory Multiple Myeloma
- 28:40
- 14 күн бұрын
Bispecific Antibody Therapy in Multiple Myeloma
- 26:59
- 14 күн бұрын
Updates on AL Amyloidosis Treatment: What’s New in 2024
- 35:27
- 14 күн бұрын
Updates in Multiple Myeloma in 2024: From Bench to Bedside
- 22:48
- 14 күн бұрын
CAR T Cells in Multiple Myeloma
- 18:54
- 14 күн бұрын
Multiple Myeloma 101: Diagnosis, Prognosis, and Risk
- 1:19
- 14 күн бұрын
Пікірлер